Other safety alerts
|
| |
| Canada: Unauthorized Kobayashi Eyebon Eye Wash seized from Oceanbuy store and removed from website because it may pose serious health risks |
| |
Health Canada is warning consumers about an unauthorized health product, Kobayashi Eyebon Eye Wash, Cool format, which it seized from Oceanbuy, a store located in Markham ON, and removed from online sale. The unauthorized product was labelled in Japanese to contain aminocaproic acid, a prescription drug used to decrease bleeding in various clinical situations.
The product is promoted as an eye wash for contact lens users and for the prevention of eye disease. Exposure to aminocaproic acid in the eye may affect the eye itself, and the acid may be absorbed through the tear ducts into the blood. Side effects may include watery eyes, blurry or reduced vision, headache, dizziness, nausea, muscle weakness and skin rash.
Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.
Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/unauthorized-kobayashi-eyebon-eye-wash-seized-oceanbuy-store-and-removed-website
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website since 29 Aug 2017, with the latest update posted on 1 Apr 2021.
Ends/Thursday, Feb 23, 2023
Issued at HKT 14:30
|
| |
|
